Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers

European Journal of Medicinal Chemistry

Volumn 54, Issue , 2012, Pages 429-438

  Varshosaz, Jaleh ^a   Hassanzadeh, Farshid ^a   Sadeghi, Hojjat ^a   Andalib, Sare ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 FU; Colorectal cancer; Cytotoxicity; HT29 cell line; Octadecylamine; Retinoic acid; Targeted NLCs

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; DRUG CARRIER; FLUOROURACIL; LIPID; LOW DENSITY LIPOPROTEIN; NANOMATERIAL; OCTADECYLAMINE; OCTADECYLAMINE RETINOIC ACID CONJUGATE; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; COLON CANCER; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; EMULSION; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY;

AMINES; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY TECHNIQUES, SYNTHETIC; CHOLESTEROL; DRUG CARRIERS; FLUOROURACIL; HT29 CELLS; HUMANS; NANOSTRUCTURES; RECEPTORS, LDL; STRUCTURE-ACTIVITY RELATIONSHIP; TRETINOIN;

EID: 84864404661     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.05.024     Document Type: Article

References (30)

1. A.E.B. Yassin, M.K. Anwer, H.A. Mowafy, I.M. El-Bagory, M.A. Bayomi, and I.A. Alsarra Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer Int. J. Med. Sci. 7 2010 398 408
2. S. Li, A. Wang, W. Jiang, and Z. Guan Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles BMC Cancer 8 2008 103 121
3. M. Radtk, E.B. Souto, and R.H. Müller Nanostructured lipid carriers: a novel generation of solid lipid drug carriers Pharm. Technol. Eur. 17 2005 45 50 (Pubitemid 40468236)
4. C.W. How, R. Abdullah, and R. Abbasalipourkabir Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80 Afr. J. Biotechnol. 10 2011 1684 1689
5. Y. Zheng, P.M. Kramer, R.A. Lubet, V.E. Steele, G. Kelloff, and M.A. Pereira Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci Carcinogenesis 20 1999 255 260 (Pubitemid 29057558)
6. P.J. O'Dwyer, T.S. Ravikumar, D.P. McCabe, and G. Steele Jr. Effect of 13-cis-retinoic acid on tumor prevention, tumor growth, and metastasis in experimental colon cancer J. Surg. Res. 43 1987 550 557 (Pubitemid 18019253)
7. B.K. Murray, B. Brown, P.M. Scherer, D.P. Tomer, K.R. Garvin, B.G. Hughes, and K.L. O'Neill Induction of apoptosis in HT-29 human colon adenocarcinoma cells by 13-cis-retinoic acid and vitamin E succinate Nutr. Res. 26 2006 186 192 (Pubitemid 43831389)
8. J. Fang, H. Wei, Z. Zheng, J. Liu, B. Hu, and J. Huang Expression of retinoic acid receptor β in human colorectal cancer Afr. J. Biotechnol. 9 2010 6783 6786
9. E.Y. Park, A. Dillard, E.A. Williams, E.T. Wilder, M.R. Pepper, and M.A. Lane Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism Cancer Res. 65 2005 9923 9933 (Pubitemid 41541473)
10. M.O. Bradley, N.L. Webb, F.H. Anthony, P. Devanesan, P.A. Witman, S. Hemamalini, M.C. Chander, S.D. Baker, L. He, S.B. Horwitz, and C.S. Swindell Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel Clin. Cancer Res. 7 2001 3229 3238 (Pubitemid 32963848)
11. B.S. Chhikara, N. St Jean, D. Mandal, A. Kumar, and K. Parang Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities Eur. J. Med. Chem. 46 2011 2037 2042
12. B.S. Chhikara, D. Mandal, and K. Parang Synthesis and evaluation of fatty acyl ester derivatives of cytarabine as anti-leukemia agents Eur. J. Med. Chem. 45 2010 4601 4608
13. S. Vitols, G. Gahrton, M. Bjorkholm, and C. Peterson Hypocholesterolemia in malignancy due to elevated LDL receptor activity in tumor cells: evidence from studies in patients with leukaemia Lancet 2 1985 1150 1154
14. A. Niendorf, H. Ngele, D. Gerding, U. Meyer-Pannwitt, and A. Gebhardt Increased LDL receptor mRNA expression in colon cancer is correlated with a rise in plasma cholesterol levels after curative surgery Int. J. Cancer 61 1995 461 464
15. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
16. P. Costa, J. Manuel, and S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133 (Pubitemid 32288781)
17. M.E. Nita, H. Nagawa, O. Tominaga, N. Tsuno, S. Fujii, S. Sasaki, C.G. Fu, T. Takenoue, T. Tsuruo, and T. Muto 5-fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins Br. J. Cancer 78 1998 986 992 (Pubitemid 28463972)
18. H.H.J. Backus, D.F. Dukers, C.J. van Groeningen, W. Vos, E. Bloemena, D. Wouters, J.M.G.H. van Reil, K. Smid, G. Giaccone, H.M. Pinedo, and G.J. Peters 5-fluorouracil induced fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients Ann. Oncol. 12 2001 209 216 (Pubitemid 32223870)
19. H.A.E. Benson, V. Sarveiya, S. Risk, and M.S. Roberts Influence of anatomical site and topical formulation on skin penetration of sunscreens Ther. Clin. Risk Manag. 1 2005 209 218
20. R. Rai, and C.R. Srinivas Photoprotection Indian J. Dermatol. Venereol. Leprol. 73 2007 73 79 (Pubitemid 46675028)
21. M. Patel, S.K. Jain, A.K. Yadav, D. Gogna, and G.P. Agrawal Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sun screening efficacy Drug Deliv. 13 2006 323 330 (Pubitemid 44180012)
22. S.A. Wissing, and R.H. Muller The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles Int. J. Pharm. 242 2002 373 375
23. J. Pardeike, A. Hommoss, and R.H. Muller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 2009 170 184
24. V. Jenning, A.F. Thunemann, and S.A. Gohla Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2000 167 177 (Pubitemid 30236188)
25. R.H. Muller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
26. R.W. Mahley, T.L. Inncrarity, S.C. Rail, and K.H. Weisgraber Plasma lipoproteins: apolipoprotein structure and function J. Lipid Res. 25 1984 1277 1294 (Pubitemid 15150638)
27. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47 (Pubitemid 16037973)
28. M.S. Brown, and J.L. Goldstein Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic J. Clin. Invet. 72 1983 743 747 (Pubitemid 14211383)
29. R. Hegg, J. Carvalho, S.R. Graziani, C.J. Valduga, D.C. Fernandes, C.H.M. Azevedo, A.C. Loprete, D.G. Rodrigues, and R.C. Maranhao Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein (LDL) receptors as a vehicle for etoposide Proc. Am. Soc. Clin. Oncol. 22 2003 584
30. K.V. Pinheiro, V.T. Hungria, E.S. Ficker, C.J. Valduga, C.H. Mesquita, and R.C. Maranhão Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE Cancer Chemother. Pharmacol. 57 2006 624 630 (Pubitemid 43237847)